Activation of MAPK or NF-κB signaling pathways is thought to contribute to AD pathogenesis through various mechanisms, including induction of neuronal apoptosis and APP phosphorylation (Kim and Choi, 2010; Sun et al., 2022). Here, NFKB1 is linked to Alzheimer disease.